Pharmaceutical

Illumina to divest Grail after two years of lawsuits 

Illumina aims to finalise the terms of this divestiture by the end of the second quarter of 2024.

Dec 18, 2023 - 10:51
Illumina to divest Grail after two years of lawsuits 
Illumina aims to finalise the terms of this divestiture by the end of the second quarter of 2024.
Read the original article

Tags:

Previous Article

Magazine: Advancing islet transplantation for type 1 diabetes

Next Article

Novo Nordisk Foundation sets up airborne infection vaccine initiative

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Listen: How the legal battle over abortion could thwart research, plus: the FDA ‘bully pulpit’ and Moderna’s future

Listen: How the legal battle over abortion could thwart...

Apr 13, 2023

STAT+: Vaccines save lives and generate profits. Why is investment lagging?

STAT+: Vaccines save lives and generate profits. Why is...

Jan 26, 2024

ConSynance wins FDA designation for Prader-Willi syndrome therapy

ConSynance wins FDA designation for Prader-Willi syndro...

Jul 26, 2024